Aida Zarfeshani

机构：Feinstein Institute for Medical Research, SignPath Pharma (United States), Menlo School · ORCID：0000-0003-2261-0662

发表论文 15 篇 · 总被引 192 次 · h-index 8

代表论文

Lupus autoantibodies initiate neuroinflammation sustained by continuous HMGB1:RAGE signaling and reversed by increased LAIR-1 expression (2024 · Nature Immunology · 被引 36)
Leucine alters hepatic glucose/lipid homeostasis via the myostatin-AMP-activated protein kinase pathway - potential implications for nonalcoholic fatty liver disease (2014 · Clinical Epigenetics · 被引 30)
MicroRNA Expression Relating to Dietary-Induced Liver Steatosis and NASH (2015 · Journal of Clinical Medicine · 被引 26)
Effect of Lactobacillus casei on the Production of Pro-Inflammatory Markers in Streptozotocin-Induced Diabetic Rats (2011 · Probiotics and Antimicrobial Proteins · 被引 25)
New melanocortin-like peptide of E. coli can suppress inflammation via the mammalian melanocortin-1 receptor (MC1R): possible endocrine-like function for microbes of the gut (2017 · npj Biofilms and Microbiomes · 被引 24)
Cognitive Impairment in SLE: Mechanisms and Therapeutic Approaches (2021 · Current Rheumatology Reports · 被引 18)